Proud To Be
Recognized As One Of
The Nation’s Best.
We are now an NCI-designated Comprehensive Cancer Center.
University of Maryland Greenebaum Comprehensive Cancer Center has achieved the
National Cancer Institute’s highest designation. While this is an honor, what’s more
important is the progress we are making in fighting and preventing cancer:
• Discovery of galeterone, an FDA fast-tracked
compound developed to treat hormoneresistant prostate cancer
• Invention of GammaPod™, a radiotherapy
system for treating breast cancer in a prone
position to better protect the heart
• Immunotherapy trials that train patients’
own T cells to attack blood, lung, and head
and neck cancers
• Population health-related discoveries with risk
and prevention implications for cervical cancer
Learn more at UMGCCC.org